New Health Legislation Aims to Improve Patient Access and Care

In a session concentrated on public health legislation, Congressman Brett Guthrie from Kentucky, Chairman of the House Committee on Energy and Commerce, presented several bills aimed at enhancing health services and preventive measures. A key proposal is the H.R. 1703, Choices for Increased Mobility Act of 2025. Led by Representative Joyce from Pennsylvania, this legislation seeks to clarify Medicare Part B payment policies for manual wheelchairs and update coding for ultralightweight models, ultimately improving accessibility for Medicare beneficiaries utilizing these critical mobility aids.

Another pivotal bill discussed was H.R. 2715, Destruction of Hazardous Imports Act. Spearheaded by Representatives Higgins and Carter of Louisiana, this legislation would empower the FDA to mandate the destruction of imports denied entry into the United States due to public health risks. It seeks to address the issue of "port-shopping," where previously refused products attempt re-entry through alternative ports, thereby enforcing a more stringent regulatory compliance framework against illicit goods.

The session also highlighted H.R. 2821, FDA Modernization Act 3.0, backed by Representatives Carter of Georgia and Barragan. This bill proposes revisions to Health and Human Services regulations by transitioning from traditional animal testing to "nonclinical" testing frameworks. This shift responds to ethical and scientific critiques of animal testing, advocating for modern, less invasive research methodologies.

Chairman Guthrie supported the reauthorization of the Kay Hagan Tick Act via H.R. 4348. Supported by Representatives Smith and Doggett, this legislation continues efforts to manage vector-borne diseases through regional excellence centers and coordinated health department initiatives. The session also covered H.R. 5160, the reauthorization of the Stem Cell Therapeutic and Research Reauthorization Act, led by Representatives Smith and Matsui, which facilitates patient access to potentially life-saving blood stem cell transplants.

Additionally, H.R. 3747, the Accelerating Access to Dementia and Alzheimer's Provider Training (AADAPT) Act, aims to advance healthcare provider training via technology-enabled programs. This initiative, supported by Representatives Balderson and Barragan, enhances specialty care access in underserved communities. Moreover, H.R. 2001 addresses dental workforce shortages through grant programs, introduced by Representatives Kelly and Simpson, emphasizing oral health's role in overall wellness.

For traumatic brain injury (TBI) programs, H.R. 1493 seeks to reauthorize federal initiatives to enhance TBI prevention, rehabilitation, and patient advocacy, led by Representatives Pallone and Bacon, highlighting the importance of preparedness and resources. H.R. 4541, the EARLY Act Reauthorization of 2025, focuses on breast cancer education and outreach for young women, guided by Representatives Wasserman Schultz and Miller-Meeks.

Also discussed was the DeOndra Dixon INCLUDE Project Act of 2025 under H.R. 3491, supporting NIH research into Down syndrome, aiming to improve health outcomes for affected individuals. Additionally, H.R. 6238, the NIH IMPROVE Act, led by Representatives Underwood and Fitzpatrick, promotes research into preventable maternal health issues. Finally, the reauthorization of the Accelerating Access to Critical Therapies for ALS Reauthorization Act, H.R. 8205, supported by Representatives Quigley and Calvert, continues to expand therapy options for ALS patients and those with similar conditions.

These legislative efforts underscore a commitment to enhancing health systems, improving patient access to care, and achieving better outcomes across a diverse range of health challenges.